Fny Investment Advisers, LLC Cellectar Biosciences, Inc. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$8.2 - $12.4 $1.81 Million - $2.73 Million	-220,321 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$11.2 - $27.7 $190,400 - $470,900	17,000 Added 8.36%	220,321 $458,000
Q3 2020 Oct 09, 2020	BUY	$10.6 - $16.6 $795,000 - $1.25 Million	75,000 Added 58.45%	203,321 $252,000
Q2 2020 Jul 10, 2020	BUY	$10.3 - $17.3 $604,826 - $1.02 Million	58,721 Added 84.37%	128,321 $164,000
Q1 2020 Apr 09, 2020	BUY	$11.0 - $31.7 $765,600 - $2.21 Million	69,600 New	69,600 $88,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $13M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.